The Venture Codex

Participated · Series A · Dec 2023

Prevu operates a digital home-buying platform that lets buyers search for homes, schedule tours, draft offers and collaborate with a dedicated salaried agent, with an Amazon-like user experience. The company hires agents as salaried employees with benefits and pays them a small commission while offering buyers cash-back rebates drawn from the buyer-agent commission. Since launching its digital platform in June 2017, Prevu has helped over 1,200 buyers purchase homes totaling more than $1.5 billion and says it has saved consumers an average of $23,000 per purchase. Prevu currently operates in 12 major metropolitan markets and has 25 employees, most of whom are agents; its average agent completes about 40 deals per year. The startup generates revenue from net commission on each transaction (1% to 1.5% of transaction value, net of customer rebate) and reports annual revenue growth of nearly 10x since its 2019 seed round. It plans to expand into additional markets (including Texas and Florida), add mortgage, title and other buyer-related services—bolstered by its purchase of mortgage technology from Reali—and aims to become a nationwide brand. Prevu operates a Smart Buyer™ digital platform that lets consumers search, offer, schedule tours, and complete purchases with expert agent support during the final stages. The company emphasizes buyer control and transparency, passing two‑thirds of agent commission back to buyers and offering rebates of up to 2%. Customers who have purchased through Prevu have received average rebates of $23,000. Prevu launched its Smart Buyer™ platform in 2017 and currently operates in the New York Metropolitan Area and Connecticut. The product combines online tools with local agents who step in for negotiation and closing, aiming to reduce agent time spent on new‑client acquisition and increase service efficiency. The company plans to use new funding to grow its engineering team and strategically expand into new geographic markets.

Participated · Seed · Mar 2022

Cambium operates a supply‑chain technology platform that connects tree care services, sawmills, manufacturers, and logistics to transform salvaged wood into Carbon Smart™ Wood products, millwork, and now mass timber. The company digitizes and streamlines the traditionally fragmented wood industry with chain‑of‑custody tracking, inventory and logistics tools, POS, e‑commerce, and AI/LLM‑driven efficiency solutions. Cambium is manufacturing cross‑laminated timber (CLT) from salvaged wood through partnerships with CLT producers and is expanding mass timber offerings to substitute steel and concrete in buildings. It has moved over 8 million board feet of wood, sequestered more than 10,000 tonnes of CO2e, and built a network of 350+ tree care companies, sawmills, and trucking partners. Recent strategy includes scaling distribution of Carbon Smart™ Wood, broadening logistics via the Mill Market acquisition (July 2024), and pursuing additional M&A to bolster supply‑chain infrastructure. The company intends to use new capital to deploy AI across the $788B wood products industry, grow the team, and scale operations to meet rising demand for traceable, low‑carbon building materials. Cambium Carbon operates Traece, a SaaS platform that connects trees to local sawyers and millers to turn them into durable products that store carbon and fund community tree planting. The platform enables a supplier network through which real estate developers, tech companies, and furniture manufacturers purchase Carbon‑Smart Wood. Traece has moved $3.7M of wood to date. The company raised $3.2M in seed funding to scale operations. Cambium plans to use the funds to grow its team, expand platform user‑ship, divert 2,500 tons of wood waste, and plant 10,000 high‑impact trees in partnership with communities. It was founded by Ben Christensen, Marisa Repka and Theo Hooker.

Participated · Series C · Feb 2022

Humu is an action management platform that uses behavioral science and technology to nudge managers and teams to build specific habits that drive organizational success. The system pinpoints which behaviors and people skills leaders, managers, and employees need to be effective and helps customers improve managers, increase agility, build more inclusive cultures, and boost team performance. Led by CEO Laszlo Bock, Humu works with organizations including Expedia Group, Kickstarter, and sweetgreen. The company raised $60M in a Series C to expand its reach. Humu intends to use the funds to boost product development and hiring to bring its behavioral science software to more companies, managers, and employees. The platform’s core focus remains on turning behavioral science into weekly, actionable improvements for employees and managers. Humu is a Mountain View, Calif.-based behavioral-change software company. It provides a technology platform that measures what matters most to employees and incentivizes leaders, managers, and employees toward positive behavioral change. The platform aims to improve productivity in real time and to drive retention and happiness at work. The company was co-founded by CEO Laszlo Bock, Wayne Crosby, and Jessie Wisdom. Humu raised $30m in a Series B and intends to use the funds to expand operations.

Participated · Series A · Feb 2022

Formlogic provides autonomous precision manufacturing services intended for space companies. It separates engineering from physical labor by combining remote AI-based planning with autonomous production. The company has developed software that performs the simulations needed to produce parts effectively, replacing traditional guess-and-check methods performed by skilled workers. Formlogic operates factories in Pittsburgh spanning over 50,000 square feet. The company plans to use recent growth capital to acquire new CNC machines and continue scaling operations. Leadership frames the mission as modernizing the industrial supply chain and retaining skilled manufacturing in the U.S. Formlogic replaces manual trial-and-error in precision machining with simulation-driven software and autonomous production, decoupling engineering decisions from physical labor. Its RemoteShop console enables remote experts to plan and run production from anywhere. The company has secured purchase orders from ten leading customers across the medical, automotive, and aerospace industries, and reports all machines operating at or near capacity. Formlogic is pursuing enterprise customers that could each represent roughly $1 million a year in sales. The approach targets a highly fragmented machine tool consumption market valued at over $70 billion, where no incumbent holds more than 1.0% share. The team is led by founder and CEO Paul Sutter, who previously exited companies to AltaVista and Citrix and grew a prior business to $400 million in revenue, and CTO David Montague, formerly of Palantir, alongside aerospace veterans from SpaceX.

Participated · Series C · Aug 2021

Genome Medical operates as an independent virtual medical practice powered by a digital health technology platform (its Genome Care DeliveryTM platform) to deliver on-demand genetic insights, clinical assessments, test ordering and personalized care plans. The company partners with health systems, providers, health plans, employers, labs and biopharma to expand access to genomic medicine. Genome Medical announced the acquisition of GeneMatters, which will operate as a wholly owned subsidiary focused on expanding genetic services to community health systems and other partners. The company plans to use proceeds from its recent financing to expand its team and further develop configurable technology solutions, physician services, test ordering capabilities and guidelines-based care plans. Headquartered in South San Francisco, Genome Medical positions itself to accelerate adoption of genomic services across health systems, research studies, health plans, employers and diagnostic labs. Genome Medical is a telegenomics technology, services and strategy company that delivers virtual genetic care through a nationwide network of genetic specialists and its Genome Care Delivery technology platform. The company provides expert virtual genetic care for individuals and their families and helps health care providers and patients navigate genetics to understand disease risk, accelerate diagnosis, inform treatment decisions and lower cost of care. Its solutions are utilized by health systems, hospitals, payors, providers and employers, and the company also serves patients directly and accepts self-referrals. Led by CEO and co-founder Lisa Alderson, Genome Medical focuses on applying genomic-based medicine across clinical settings. The company intends to use new funding to accelerate development of its Genome Care Delivery platform for cancer, reproductive health and pharmacogenomics. Since 2016 the company has raised a total of $60M, including the latest round. Genome Medical operates a cloud-based genomic care delivery platform that provides on-demand access to genetic experts for virtual visits, provider-to-provider consults, genetic wellness assessment, and screening for population health management. The company partners with hospitals, health systems, payers, providers, and employers to make genomic medicine accessible to patients nationwide. Led by co-founder and CEO Lisa Alderson, Genome Medical is based in South San Francisco, California. The company plans to scale its team of clinical genomics specialists and accelerate development of its proprietary genomic care delivery platform using the new funding. Financially, Genome Medical has raised a total of $46M since its founding in 2016, including the current Series B. The new capital is intended to expand service delivery and product development across its healthcare and employer customers. Genome Medical operates a telegenomics platform that connects a network of clinical genetics experts with patients and clinicians to provide genetic counseling and physician services. The company delivers genetic counseling in all 50 states and physician services in 30 states, covering nearly three-quarters of the U.S. population. It accepts insurance billing, institutional billing, and direct patient payment. Genome Medical plans to expand all services nationwide in 2018 and to deepen clinical offerings in cancer genetics, cardiovascular genetics, reproductive health and proactive health. The company was co-founded in 2016 and is headquartered in San Francisco. It has raised more than $23 million in financing to date. Genome Medical operates a telehealth platform that connects patients with genetic counselors, geneticists, or contracted specialists for phone or video consultations. The service is designed to increase access and reduce wait times, offering next-day scheduling and working toward same-day appointment capabilities. Consultations currently cost $149 for a video visit, and the company is pursuing insurance coverage. Genome Medical offers both pre-test “proactive health” counseling and post-test consultations that include a detailed clinical action plan. The company has formed partnerships (including Good Start Genetics) and is building out a team of doctors to integrate genetic testing into clinical care. It was founded by CEO Lisa Alderson with Randy Scott and Harvard Medical School geneticist Robert Green and has raised $12 million in funding from institutional investors.